OIG Warns That Paying for Preferential Access to Referral Opportunities May Violate the Anti-Kickback Statute

Healthcare providers, health systems, telehealth companies, pharmacies, digital health companies, and healthcare technology vendors should carefully evaluate arrangements involving referral management platforms and patient acquisition services following a recent unfavorable advisory opinion issued by the HHS Office of Inspector General (“OIG”). The opinion addresses a digital referral management platform used during hospital discharge planning and signals continued government scrutiny of arrangements that provide paying participants with a competitive advantage in obtaining federally reimbursable patients.

OIG Advisory Opinion 26-15 involved a home health agency that paid subscription fees to access a digital referral management platform used by hospitals during the discharge planning process. OIG concluded that the proposed arrangement could violate the Federal Anti-Kickback Statute (“AKS”) because participating providers were effectively paying for preferential access to referral opportunities involving federal healthcare program beneficiaries. While the opinion arose in the home health context, its implications extend far beyond a single provider type and should be carefully considered by organizations that rely on technology platforms to connect with potential patients.

Why This Matters

Healthcare providers increasingly use technology to facilitate patient referrals, care coordination, discharge planning, scheduling, patient matching, and provider selection. Digital platforms now play a significant role in connecting patients with providers across numerous healthcare sectors, including home health, telehealth, behavioral health, pharmacy services, durable medical equipment, post-acute care, and specialty physician services.

As healthcare delivery becomes more dependent on technology, providers frequently enter subscription, participation, licensing, and marketing arrangements with third-party vendors that promise increased visibility, enhanced access to referral opportunities, or streamlined patient acquisition. Although these arrangements may offer operational benefits, they can also raise significant compliance concerns if compensation is tied, directly or indirectly, to obtaining federally reimbursable patients.

The OIG advisory opinion serves as a reminder that the government continues to scrutinize arrangements where providers pay for advantages in the referral process, particularly when those advantages may influence which providers receive patient referrals.

How the Arrangement Worked

The requestor operated home health agencies that frequently received referrals from hospitals for post-discharge care. The provider sought to participate in a digital referral management platform that connected hospitals with home health agencies during discharge planning. Hospitals using the platform could electronically transmit referral requests to participating providers, and subscribing providers could immediately review and respond to those requests through the platform.

According to the facts presented to OIG, providers that did not subscribe to the platform were required to rely on alternative communication methods, including fax, email, telephone calls, or manual delivery of referral information. Because referrals were often awarded on a first-come, first-served basis, OIG concluded that providers paying for access to the platform obtained a significant competitive advantage over non-participating providers.

OIG further noted that non-subscribed providers could be effectively excluded from referral opportunities because delays associated with traditional communication methods reduced their ability to compete for patients being discharged from participating hospitals.

OIG’s Analysis

OIG concluded that the arrangement implicated the Anti-Kickback Statute because the provider was paying remuneration to a third-party vendor in connection with obtaining referral opportunities involving federal healthcare program beneficiaries. OIG also determined that the arrangement did not satisfy the regulatory safe harbor for referral services.

The agency expressed concern that participating providers gained an advantage in obtaining patients because they paid for access to the platform rather than because of the quality of services, they offered. OIG further concluded that the arrangement created risks of patient steering and unfair competition because providers willing or able to pay subscription fees could receive referrals that might otherwise be available to competing providers.

The opinion also highlighted concerns regarding overutilization. OIG observed that providers incurring costs to participate in such arrangements may face pressure to recover those costs through increased utilization of reimbursable services. The agency noted that these incentives can contribute to unnecessary services and increased costs to federal healthcare programs.

Why the Anti-Kickback Statute Matters

The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving remuneration in exchange for referrals of items or services reimbursable by Medicare, Medicaid, or other federal healthcare programs. The statute is intended to protect patients and federal healthcare programs from financial arrangements that may improperly influence healthcare decision-making.

When financial incentives affect referral decisions, patients may be directed to providers based on economic considerations rather than clinical judgment, quality outcomes, patient preference, or medical necessity. Such arrangements can increase healthcare costs, distort competition, undermine patient choice, and create patient safety concerns.

The government has long viewed improper referral relationships as creating incentives for unnecessary testing, treatment, procedures, equipment, and services. For this reason, Anti-Kickback Statute enforcement remains a significant priority for OIG and the U.S. Department of Justice.

Implications for Healthcare Providers and Technology Vendors

Although the advisory opinion involved a home health agency, the underlying principles apply to a broad range of healthcare organizations. Providers increasingly rely on referral management platforms, patient-matching services, telehealth networks, discharge planning systems, digital health marketplaces, pharmacy marketing arrangements, and other technology solutions designed to facilitate patient acquisition.

Organizations should carefully evaluate whether payments to vendors represent compensation for legitimate technology, administrative, or operational services, or whether the arrangement effectively provides preferential access to referral opportunities. Attention should be paid to whether paying participants receive enhanced visibility, faster access to referrals, exclusive opportunities, preferred placement, or other advantages unavailable to competitors.

Technology vendors operating in the healthcare space should likewise assess whether their business models create actual or perceived incentives tied to referral generation, patient steering, or the volume or value of federally reimbursable business.

Key Takeaway

OIG Advisory Opinion 26-15 demonstrates that the government remains focused on arrangements that provide paying providers with a competitive advantage in obtaining federally reimbursable patients. While technology continues to transform healthcare delivery and referral management, organizations should ensure that innovation does not outpace compliance.

Healthcare providers and technology vendors should review referral management arrangements, patient acquisition programs, platform subscription agreements, and related business models to determine whether compensation could be viewed as payment for referral opportunities rather than fair-market-value services. Early legal and compliance review may help organizations identify and address potential Anti-Kickback Statute concerns before they become the subject of audits, investigations, recoupments, civil monetary penalties, exclusion actions, or other enforcement activity.

This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services. The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel. The views and opinions expressed herein represent those of the individual author(s) only and are not necessarily the views of Clark Hill PLC or Clark Hill Solicitors LLP. Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness.